- Home
- IMUX vs SLQT Comparison
IMUX vs SLQT Comparison
Compare IMUX & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMUX | SLQT |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | United States |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.2M | 204.6M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IMUX | SLQT |
|---|---|---|
| Price | $14.99 | $0.72 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | ★ $36.00 | $2.88 |
| AVG Volume (30 Days) | 174.0K | ★ 2.2M |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.00 | ★ 105.00 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $1,526,594,000.00 |
| Revenue This Year | N/A | $10.97 |
| Revenue Next Year | N/A | $6.14 |
| P/E Ratio | ★ N/A | $6.52 |
| Revenue Growth | N/A | ★ 15.50 |
| 52 Week Low | $0.51 | $0.56 |
| 52 Week High | $15.84 | $2.77 |
Technical Indicators
Market Signals| Indicator | IMUX | SLQT |
|---|---|---|
| Relative Strength Index (RSI) | 59.12 | 38.98 |
| Support Level | $0.74 | $0.56 |
| Resistance Level | $15.81 | $0.94 |
| Average True Range (ATR) | 0.82 | 0.07 |
| MACD | -0.14 | -0.01 |
| Stochastic Oscillator | 51.75 | 3.26 |
Price Performance
Historical ComparisonAbout IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.